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Abstract
The insulin-like growth factor I receptor (IGF-IR) is exceptionally overexpressed in many
cervicalcancer-derived cell lines. It is postulated that a decrease of p53 protein levels due to human
papillomavirus (HPV) infection may contribute to the up-regulation of IGF-IR expression in cervi-
cal cancer cells because transcription of IGF-IR is strictly down-regulated by p53. To evaluate this
fact in clinical cervical cancer specimens, we checked the expression levels and activated status
of IGF-IR by immunohistochemistry. Formalin-fixed and paraffin-embedded specimens obtained
by conization or hysterectomy were stained with anti-IGF-IR and with an antibody recognizing
phosphorylated tyrosine at its c-terminus. The expression levels of IGF-IR were significantly high
in cervical intraepithelial neoplasia (CIN) III and invasive cancer specimens. Phosphorylation of
IGF-IR was promoted in all CIN and invasive cancer specimens, and its intensity was related to
the promotion of lesions. Interestingly, IGF-IR overexpression was missing in the basal layer of
CIN I and II lesions, whereas it was evenly distributed in CIN III and invasive cancer lesions. This
IGF-IR overexpression pattern may be utilized in the diagnosis of HPV infection status in CIN
lesions.
KEYWORDS: insulin-like growth factor I receptor, cervical cancer, human papillomavirus, ty-
rosil phosphorylation
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The insulin-like growth factor I receptor (IGF-IR) is exceptionally overexpressed in many cervical-
cancer-derived cell lines. It is postulated that a decrease of p53 protein levels due to human papilloma-
virus (HPV) infection may contribute to the up-regulation of IGF-IR expression in cervical cancer cells 
because transcription of IGF-IR is strictly down-regulated by p53.  To evaluate this fact in clinical 
cervical cancer specimens,  we checked the expression levels and activated status of IGF-IR by immu-
nohistochemistry.  Formalin-ﬁxed and paraﬃn-embedded specimens obtained by conization or hyster-
ectomy were stained with anti-IGF-IR and with an antibody recognizing phosphorylated tyrosine at its 
c-terminus.  The expression levels of IGF-IR were signiﬁcantly high in cervical intraepithelial neopla-
sia (CIN) III and invasive cancer specimens.  Phosphorylation of IGF-IR was promoted in all CIN and 
invasive cancer specimens,  and its intensity was related to the promotion of lesions. Interestingly,  
IGF-IR overexpression was missing in the basal layer of CIN I and II lesions,  whereas it was evenly 
distributed in CIN III and invasive cancer lesions.  This IGF-IR overexpression pattern may be utilized 
in the diagnosis of HPV infection status in CIN lesions.
Key words:  insulin-like growth factor I receptor,  cervical cancer,  human papillomavirus,  tyrosil phosphorylation
t is widely recognized that human papillomavi-
rus (HPV) infection is the fundamental cause of 
cervical cancer [1,  2].  Previous reports 
revealed that almost 90ｵ of cervical cancer patients 
were HPV-positive.  The commonly used method for 
HPV detection is a polymerase-chain-reaction (PCR)-
based ampliﬁcation of the HPV L1 region by consen-
sus primers.  Therefore,  the exact incidence of HPV 
infection,  especially in invasive cervical cancer,  might 
be higher because the L1 region of HPV is often dis-
rupted upon integration of the HPV genome into the 
chromosomes.  Actually,  one report showed the inci-
dence of HPV infection in invasive cervical cancer to 
be as high as 99.7ｵ after re-evaluation by type-spe-
ciﬁc PCRs for the E7 gene,  indicating that HPV 
plays an essential role in the carcinogenesis of cervical 
cancer [3].  The oncogenic functions of two HPV 
early proteins,  E6 and E7,  are well established: E6 
binds to p53 by forming a trimeric complex with the 
cellular ubiquitin ligase E6-associated protein,  and the 
p53 is rapidly degraded by proteasomes [4ﾝ6]; E7 
binds to hypophosphorylated pRB,  which is then rap-
idly degraded by proteasomes; thereby pRB constitu-
tively releases transcriptional factor E2F [7ﾝ9].  The 
loss of function of these 2 major tumor suppressor 
gene products due to infection with HPV is a funda-
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mental cause of the carcinogenesis of cervical cancer.  
However,  the whole mechanism of cervical cancer 
carcinogenesis after the inactivation of p53 and pRB 
remains to be elucidated.
　 Insulin-like growth factor I receptor (IGF-IR) is a 
tyrosine-kinase receptor which is located on the cel-
lular membranes of normal cells as well as various 
cancer cells.  Para-crine or auto-crine stimulation of 
IGF-IR with its ligand IGF-I,  IGF-II,  and insulin at 
supra-physiological concentrations leads to tyrosine 
auto-phosphorylation of IGF-IR,  followed by trans-
phosphorylation of its substrates IRS-1 and Shc,  and 
tranduces various signals via PI3-kinase and MAP-
kinase pathways.  IGF-IR and IGF-I are essential for 
the establishment and maintenance of cellular trans-
formation [10,  11].  Over-expression of IGF-IR 
and/or IGF-I has been reported to be associated with 
poor prognoses such as a high incidence of lymph node 
metastasis and a low survival rate in many kinds of 
malignancies [12,  13].
　 The expression of IGF-IR is usually not extremely 
high in many human cancer-derived cell lines,  because 
the overexpression of IGF-IR may cause hyper-diﬀer-
entiation of the cells and may result in apoptosis.  
However,  we previously reported that the transcrip-
tion of IGF-IR was strictly down-regulated by the 
tumor suppressor gene product p53 [14].  Therefore,  
we postulated that the expression of IGF-IR in cervi-
cal cancer cells might be exceptionally high due to the 
decrease of p53 by means of the promoted proteolysis 
that is promoted after HPV infection.
　 The aim of the present study is to elucidate our 
hypothesis of IGF-IR up-regulation by HPV in human 
cervical cancer and pre-cancerous lesions,  and to 
speculate on the role of IGF-IR in the carcinogenesis 
and progression of cervical cancer and also on its 
clinical application.
Materials and Methods
　 Patients and tissue samples. Included in this 
study are cervical intraepithelial neoplasia (CIN) 
patients and cervical cancer stage 0,  stage I,  and 
stage II patients (FIGO staging classiﬁcation) who 
underwent conization or hysterectomy at Okayama 
University Hospital,  Okayama,  Japan,  between 
January 2001 and December 2003.  All subjects gave 
written informed consent.  Basically,  slices including 
the most advanced lesion within the surgical specimen 
were subjected to immunohistochemistry.  As negative 
controls,  cervical specimens from patients who under-
went hysterectomy with benign diseases such as leio-
myomas were used.  Thirty consecutive individual 
specimens for each clinical stage pathologically shown 
to be CIN or squamous cell carcinomas were used for 
the study.
　 Cells. We employed R－ and R＋ cells as nega-
tive and positive controls for immunohistochemical 
evaluation of IGF-IR expression status.  R－ cells are 
3T3-like ﬁbroblasts established from mouse embryo 
with targeted disruption of IGF-I,  IGF-II,  and IGF-IR 
genes [15].  R＋ cells are R－ cells stably transfected 
with human IGF-IR cDNA,  and currently express 9×
106 IGF-IRs per cell.  HeLa S3,  SiHa,  and C33a 
cells are cell lines derived from human cervical carci-
nomas.  These cell lines were obtained from the 
Department of Cell Biology,  Okayama University 
Graduate School of Medicine,  Dentistry and 
Pharmaceutical Sciences.  CaOV-3 and OVCAR-3 
cells are cell lines derived from human ovarian carci-
noma purchased from American Type Culture 
Collection.
　Western blot. The expression levels of IGF-IR 
in the cell lines were evaluated by western blot.  
Subconﬂuent cells were lysed in a lysis buﬀer (50mM 
Hepes pH7.5,  150mM NaCl,  1.5mM MgCl2,  1mM 
EGTA,  10ｵ glycerol,  1ｵ Triton X-100) containing 
100mM NaF,  0.2mM sodium ortho-vanadate,  10mM 
sodium pyrophosphate,  1ｵ phenylmethylsulfonyl ﬂuo-
ride,  and 1ｻg/ml aprotinin to detect the expression 
levels of IGF-IR.  Thirty micrograms of whole cell 
lysates were separated on a 5ﾝ15ｵ gradient SDS-
polyacrylamide gel,  transferred to a nitrocellulose 
membrane,  and stained with anti-IGF-IR ｹ-subunit 
antibody (C20,  Santa Cruz Biotechnology,  Inc.,  
Santa Cruz,  CA,  USA).  The blot was hybridized 
with HRP-conjugated anti-rabbit secondary antibody 
(Santa Cruz Biotechnology,  Inc.) and was developed 
using enhanced chemiluminescence detection reagents 
(Amersham Biosciences Corp.,  Piscataway,  NJ,  
USA).  To ascertain the sensitivities and speciﬁcities 
of the antibodies used in the study,  total cell lysates 
collected from R－ and R＋ cells after stimulation with 
or without IGF-I (Invitrogen/Life Technologies,  Inc.,  
Rockville,  MD,  USA) were used for western blot 
analyses. Fifty micrograms of whole cell lysates were 
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separated and stained.  Anti-IGF-IR ｹ-subunit anti-
body or anti-PY1316 antibody [16] was used as the 
primary antibody.  Anti-PY1316 antibody was raised 
from a synthetic peptide including phosphorylated 
tyrosine at amino acid position 1316.
　 Immunohistochemistry. Formalin-ﬁxed and 
paraﬃn-embedded surgical specimens were stained 
with anti-IGF-IR ｹ-subunit antibody (C-20,  Santa 
Cruz Biotechnology,  Inc.) or with anti-PY1316 anti-
body.  Sections of 4ｻm in thickness were deparaf-
ﬁnized,  rehydrated with xylene and ethanol,  and 
blocked with methanol with 3ｵ hydrogen peroxide.  
Sections were incubated with primary antibodies 
(1: 500 dilution in PBS for anti-IGF-IRｹ,  and 
1: 300 in PBS for anti-PY1316) for 2 h at room 
temperature.  Then sections were stained with Histo-
ﬁne Simple Stain MAX-PO (MULTI) and Simple 
Stain DAB Solution (Nichirei Bioscience,  Tokyo,  
Japan) according to the manufacturerʼs protocol.  The 
slides were counterstained with hematoxylin and used 
for the study.  We also used R－ cells as negative con-
trols and R＋ cells as positive controls,  respectively,  
in each staining.  R－ cells or R＋ cells were cultured on 
a Lab-TekTM Chamber SlideTM System (Thermo 
Fisher Scientiﬁc Inc.,  MA,  USA),  ﬁxed by 1ｵ for-
malin and stained in the same manner.  To evaluate 
tyrosil phosphorylation of IGF-IR,  R－ cells or R＋ 
cells were treated as described above and ﬁxed imme-
diately with formalin.
　 Staining evaluation. The intensity of staining 
was graded as 0 (negative: no staining is present or 
partial membrane staining in ＜10ｵ of malignant or 
dysplastic cells),  1＋ (light staining: weak/barely 
perceptible membrane staining in ＜10ｵ of malignant 
or dysplastic cells,  but the cells are only stained in 
part of their membrane),  2＋ (moderate staining:
weak to moderate complete membrane staining is pres-
ent in ＞10ｵ of malignant or dysplastic cells),  or 3
＋ (heavy staining: moderate to strong complete stain-
ing in ＞10ｵ of malignant or dysplastic cells).  
Microscopic analyses were evaluated independently by 
the ﬁrst 2 authors in comparison with negative and 
positive controls in the same immunohistochemistry 
series.  Final evaluations of ambiguous cases (less 
than 20ｵ of the samples) were made on a conference 
microscope with other authors.
　 Statistical analyses. Univariate analysis with 
the t-test was performed using Stat-View 5.0 software 
(Abacus Concepts,  Berkeley,  CA,  USA),  and prob-
ability values less than 0.01 were considered statisti-
cally signiﬁcant.
Results
　 IGF-IR expression levels in cervical cancer 
cell lines. We checked the expression levels of 
IGF-IR in cervical-cancer-derived cell lines to test our 
hypothesis described above.  IGF-IR was exceptionally 
overexpressed in Hela S3 cells,  harboring ～50 cop-
ies of HPV.  IGF-IR expression was also high in SiHa 
cells,  harboring 1ﾝ2 copies of HPV,  but IGF-IR 
expression in HPV-negative C33a cells was very low 
as in HPV-negative ovarian cancer cells (Fig.  1).
　 Evaluation of the antibodies by western blot.
The sensitivity and speciﬁcity of the 2 antibodies used 
for the study were evaluated by western blot.  Total 
cell lysates from R－ cells and R＋ cells cultured in 
DMEM supplemented with 10ｵ FBS or total cell 
lysates collected from R－ cells and R＋ cells with or 
without IGF-I stimulation were used.  Western blots 
with antibody against the ｹ-subunit of IGF-IR (C20) 
(Fig.  2A) and with the antibody against tyrosil-phos-
phorylated IGF-IR (PY1316) (Fig.  2B) proved that 
both of these antibodies were highly sensitive and 
speciﬁc.
　Evaluation of the antibodies by immunohis-
tochemistry. We then checked the sensitivity and 
speciﬁcity of the 2 antibodies by immunohistochemical 
staining.  Again,  R－ cells and R＋ cells were cultured 
on glass slides and stained with these antibodies.  R－ 
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Fig. 1　 IGF-IR overexpression in cervical cancer cell lines.
Thirty micrograms of total cell lysates from representative cervical 
cancer cell lines were separated in SDS-PAGE and stained with 
anti-IGF-IR ｹ-subunit.  IGF-IR is overexpressed in HPV-positive 
cervical cell lines in comparison to ovarian cancer cell lines and 
HPV-negative cervical cancer cell line C33A.
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cells with or without IGF-I stimulation were not 
stained with these antibodies,  showing high speciﬁci-
ties of the 2 antibodies (Fig.  3).  A basal level of 
IGF-IR tyrosil-phosphorylation in R＋ cells after star-
vation was detected by immunohistochemistry,  sug-
gesting a suﬃcient sensitivity of PY1316 in immuno-
histochemistry,  and phosphorylated IGF-IR was 
detected as expected in stimulated R＋ cells (Fig.  3).
　 Immunohistochemical analyses of surgical 
specimens. Surgical specimens from CIN I,  CIN 
II,  CIN III,  and squamous cell carcinomas from stage 
I and II cervical cancer patients were stained with 
anti-IGF-IRｹ or anti-phosphorylated IGF-IR antibod-
ies.  Representative pictures at each clinical stage are 
shown in Fig.  4.  IGF-IR expression was partly posi-
tive in CIN I and CIN II lesions in comparison with 
normal cervical epithelia.  In CIN III and invasive 
cervical cancer specimens,  IGF-IR expression became 
more intense,  and its expression was evenly distrib-
uted within those lesions.
　 Phosphorylation of IGF-IR was hardly visible in 
CIN I and CIN II specimens as well as in normal cer-
vical epithelium.  The intensity of IGF-IR phosphory-
lation was related to the promotion of lesions among 
CIN III and invasive cancer specimens.  Staining 
intensity by immunohistochemistry was graded from 0 
to 3＋ according to the criteria shown in the Material 
and Methods.  This staining evaluation is summarized 
in Table 1 and Table 2,  and the mean and standard 
deviation of the staining intensity of each stage are 
shown in Fig.  5.  The expression levels of IGF-IR in 
CIN III and invasive cervical cancer lesions were 
signiﬁcantly higher in comparison with normal cervical 
epithelia (Fig.  5A).  The phosphorylation status of 
IGF-IR in all stages was higher in comparison with 
normal cervical epithelia,  and its intensity increased 
in accordance with the progression of the disease 
(Fig.  5B).
　 It is of interest,  as shown in a CIN II specimen 
stained with anti-IGF-IRｹ,  that the expression of 
IGF-IR appears from intermediate cells to superﬁcial 
cells in the cervical epithelium.  In contrast,  IGF-IR 
expression in basal and para-basal cells is very faint 
(Fig.  6A).  In CIN III lesions,  the IGF-IR expression 
appears evenly in every layer of the epithelium,  and it 
becomes more intense (Fig.  6B).  So we re-evaluated 
our CIN I,  CIN II,  CIN III and stage Ia specimens 
that retained enough intact basal cell area to observe,  
and checked whether IGF-IR staining was excluded 
within basal and para-basal cells or not.  The percent-
age of this basal and para-basal cell overexpression of 
IGF-IR is shown in Table 3.  Basal cell overexpres-
sion of IGF-IR in CIN III lesions was more common in 
comparison with CIN I and CIN II lesions.
Discussion
　 The present study was intended to evaluate the 
expression levels and activated status of IGF-IR in 
human cervical cancer specimens to elucidate how 
IGF-I axis play a role in the initiation and progression 
of cervical cancer with malignant-type HPVs.  
Although we did not check investigate the prevalence 
or genotypes of HPV in the present study,  previous 
reports have already proven that almost all invasive 
cervical cancer contains malignant-type HPVs [3].
　 Immunohistochemistry with anti-IGF-IRｹ antibody 
revealed that the expression levels of IGF-IR in CIN 
254 Acta Med.  Okayama　Vol.  62,  No.  4Kuramoto et al.
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Fig. 2　 Western blot of IGF-IR expression and its phosphorylation.
Expression of IGF-IR and its tyrosil-phosphorylation were evaluated by Western blot.  Fifty micrograms of cell lysates from R－ or R＋ cells 
with or without stimulation with IGF-I were electrophoresed and stained with antibodies against IGF-IR ｹ-subunit (A) or the phosphorylated 
c-terminus of the IGF-IR (B).
4
Acta Medica Okayama, Vol. 62 [2008], Iss. 4, Art. 5
http://escholarship.lib.okayama-u.ac.jp/amo/vol62/iss4/5
III lesions and invasive squamous cell carcinoma 
lesions were signiﬁcantly higher in comparison with 
those of normal cervical epithelial cells (Fig.  5A).  
IGF-IR expression in CIN I and CIN II lesions,  
exclusively within intermediate cells,  was intensiﬁed,  
although it was not statistically signiﬁcant.  These 
limited overexpressions of IGF-IR in CIN I and CIN 
II lesions were compatible with the localization of E6 
protein expression in HPV-infected cervical epithe-
lium.  CIN I and CIN II lesions reportedly display 
viral expression patterns suggestive of productive 
viral infection [17ﾝ19].  This viral replication is 
dependent on the diﬀerentiation process of the 
infected epithelium.  Viral activity in infected basal 
cells is low,  and episomal HPVs in basal cells are 
co-replicated with the genome of the host cells.  
255IGF-IR Status in Cervical CancerAugust 2008
Table 1　 IGF-IR expression
Staining intensity 0 1＋ 2＋ 3＋
Normal 18 12  0 0
CIN I  8 20  2 0
CIN II  7 19  4 0
CIN III  5 13 10 2
Stage Ia  7 14  5 4
Stage Ib  5 10 10 5
Stage IIb  0 11 13 6
Table 2　 IGF-IR phosphorylation
Staining intensity 0 1＋ 2＋ 3＋
Normal 28  2  0  0
CIN I 27  3  0  0
CIN II 23  7  0  0
CIN III 16 10  4  0
Stage Ia  7 17  6  0
Stage Ib  0 16  9  5
Stage IIb  0  8 10 12
R－ R＋
β-subunit
PY(－IGF-I)
PY(＋IGF-I)
Fig. 3　 Immunohistochemical staining of R－ and R＋ cells.
R－ cells and R＋ cells were stained with anti-IGF-IRｹ antibody (upper panel).  Also,  R－ cells and R＋ cells were stimulated with (lower 
panel) or without (middle panel) IGF-I and stained with anti-phosphorylated IGF-IR antibody.
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β-subunit PY1316
CIN ＩＩ
CIN ＩＩI
Stage la
Stage lb
Stage lIb
Fig. 4　 Representative immunohistochemical staining with anti-IGF-IRｹ and anti-phosphorylated IGF-IR (PY1316).
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However,  viral transcription including that of E6 and 
E7 is markedly increased,  especially in intermediate 
cells,  upon diﬀerentiation of the epithelium [19].  The 
distribution of IGF-IR-overexpression in CIN I and 
CIN II lesions shown in the present study was 
co-located with that of HPV E6 oncoprotein expres-
sion during viral replication within these early 
infected lesions.  The expression of E6 in episomal 
HPV is lower than that of deregulated integrated 
HPV,  but the copy number of infected HPV in epi-
some is usually pretty high in early CIN lesions.  The 
257IGF-IR Status in Cervical CancerAugust 2008
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Fig. 6　 IGF-IR overexpression in basal and para-basal cells.
A,  A representative CIN II lesion expressing IGF-IR especially in intermediate cells and lacking its expression in basal and para-basal 
cells; B,  A representative CIN III lesion whose IGF-IR expression is evenly distributed within all epithelial layers including basal and para-
basal cells.
A B
3
2
1
0
3
2
1
0
In
te
ns
ity
In
te
ns
ity
Clinical stage Clinical stage
normal CIN I CIN II CIN III Ia Ib IIb normal CIN I CIN II CIN III Ia Ib IIb
＊ ＊
＊
＊
＊ ＊
＊
＊
＊
＊
Fig. 5　 Immunohistochemical staining intensity.
Surgical specimens were stained with anti-IGF-IRｹ (Panel A) and anti-phosphorylated IGF-IR (Panel B).  Staining intensity was graded as 
described in Materials and Methods,  and the means and standard deviations from 30 consecutive samples were compared.
＊: p＜0.01 against normal epithelium.
Table 3　 IGF-IR overexpression in basal cells
Positive Negative Positive rate (%)
Normal  0 10 0
CIN I  1 11 8.3
CIN II  3  9 25.0
CIN III  8  3 72.7
Stage Ia 12  0 100
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distribution pattern of IGF-IR overexpression in CIN 
I and CIN II in the present study (Fig.  6A) may also 
support this mechanism.
　 In contrast,  IGF-IR-overexpression in CIN III and 
invasive cervical cancer lesions were evenly distrib-
uted within the epithelium (Fig.  4),  indicating the 
deregulated expression of E6 within these lesions.  
HPV genomes in high-grade CIN lesions and cervical 
carcinoma lesions are often integrated in the host 
chromosomes [20].  E2 gene,  a repressor of E6 and 
E7 transcription,  is often disrupted upon integration 
of the HPV genome into the chromosomes,  resulting 
in the deregulated strong transcription of E6 and E7 
regardless of the replication of the host cells [21].  
Actually,  our immunohistochemical evaluation showed 
that the expression levels of IGF-IR were signiﬁcantly 
higher in CIN III and squamous cell carcinomas where 
the integration of HPV was likely.  The IGF-IR-
overexpression pattern shown in the present study was 
compatible with our hypothesis of HPV E6-induced 
transcriptional up-regulation of IGF-IR through p53 
inactivation.  The deregulated high expression of E6 
due to the integration of the HPV genome into the host 
chromosomes may be the cause of the overexpression 
of IGF-IR in CIN III and cervical squamous cell car-
cinoma lesions.
　 The detection of IGF-IR overexpression and its 
localization may be utilized to distinguish viral repli-
cation in early CIN lesions and deregulated viral 
malignant transformation leading to carcinogenesis in 
late CIN lesions.  Our immunohistochemical results 
indicated that the incidence of IGF-IR staining in basal 
cells was higher in CIN III lesions than CIN I and 
CIN II lesions (Table 3).  Although the total number 
was small,  25ｵ of CIN II lesions demonstrated 
IGF-IR overexpression in basal cells,  suggesting a 
possible integration of HPV.  Because conventional 
pathological diagnosis is based on morphology,  it does 
not always reﬂect the status of HPV infection.  It is 
also possible that a small number of CIN II lesions 
already possess integrated HPVs.  This method may 
predict the progression of the disease more precisely 
than morphological change of the cervical epithelium.
　 Although a similar strategy to detect HPV infec-
tion by immunohistochemical detection of the up-regu-
lated p16INK4A,  whose transcription is down-regulated 
by pRB,  was previously reported [22,  23],  the 
localization of p16INK4A within the epithelia has not 
been mentioned.  Since immunohistochemical evalua-
tion of IGF-IR distribution as well as p16INK4A distri-
bution within CIN lesions seems to be an alternative 
method to verify the integration status of HPV,  these 
methods can be an easier,  time-saving and less expen-
sive way to predict the prognosis of CIN lesions 
rather than conventional methods like ﬂuorescent in 
situ hybridization.
　 Aside from the IGF-IR distribution pattern within 
CIN lesions,  we could not see any correlations 
between IGF-IR overexpression and poor prognostic 
factors,  such as lymphnode metastasis,  lymph-vascu-
lar space involvement,  and deep stromal invasion.  The 
usage of IGF-IR overexpression as a prognostic factor 
for cervical cancer should be further elucidated in 
future analyses involving more samples.
　 On the other hand,  the tyrosil autophosphorylation 
status of IGF-IR was signiﬁcantly increased in all CIN 
and invasive squamous cell carcinoma lesions in com-
parison with those of normal epithelium (Fig.  5B).  
Judging from the staining intensity with the tyrosine-
phosphorylation-speciﬁc antibody,  the phosphorylation 
intensity was related to the promotion of the disease 
(Fig.  5B).  There was a discrepancy between IGF-IR 
expression levels and its activated status.  The expres-
sion levels of IGF-IR are enhanced by the deregulated 
E6 expression after the integration of HPV,  but the 
activation of IGF-IR is provided by the abundant para-
crine stimulation with its ligand IGF-I (and IGF-II) 
from surrounding cancer cells as well as stromal cells 
in advanced bulky lesions.
　 In the present study,  we conﬁrmed the overex-
pression of IGF-IR in CIN III lesions and invasive 
squamous cell carcinoma lesions,  and this overexpres-
sion could also be observed exclusively in intermedi-
ate cells in CIN I and CIN II lesions.  Since the 
overexpression of IGF-IR is likely to co-localize with 
deregulated E6 overexpression in CIN and squamous 
cervical cancer specimens,  these ﬁndings may support 
our hypothesis of IGF-IR up-regulation by HPV E6 
through deregulation from p53-induced transcriptional 
down-regulation of IGF-IR.  We also conﬁrmed that 
phosphorylation of IGF-IR increased according to the 
progression of the disease.  Along with the up-regula-
tion of IGF-IR expression by HPV E6,  this increased 
phosphorylation of IGF-IR activates IGF-I axis signal 
transduction pathways,  and possibly plays an impor-
tant role in the progression of the disease via sending 
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strong cell survival signals.
　 In conclusion,  results from the immunohistochemi-
cal evaluation of IGF-IR status in human specimens 
reconﬁrmed our hypothesis that HPV E6 induced 
up-regulation of IGF-IR by means of deregulation from 
the p53 negative loop.  This up-regulation as well as 
increased tyrosil autophosphorylation of IGF-IR from 
CIN III lesions may contribute to the initiation and 
progression of cervical cancer.  In addition,  evalua-
tion of the localization of IGF-IR overexpression in the 
cervical epithelium may be useful for distinguishing 
viral reproduction and malignant transformation in 
CIN lesions.
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